title: Introduction.
authors.affiliation: Merck and Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA. Electronic address: Beth-ann.coller@merck.com.
authors.forename: Beth-Ann
authors.initials: BA
authors.lastname: Coller
authors.affiliation: Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555, United States. Electronic address: abarrett@utmb.edu.
authors.forename: Alan D T
authors.initials: AD
authors.lastname: Barrett
authors.affiliation: The Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, United States. Electronic address: Stephen.j.thomas3.mil@mail.mil.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Thomas
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D003715:Dengue / Q000453:epidemiology / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000276:immunology* / Q000302:isolation & purification*; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D006801:Humans
chemical_list: D053059:Dengue Vaccines